CYGENICA
CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
CYGENICA
Industry:
Biotechnology
Founded:
2017-01-01
Address:
Pune, Maharashtra, India
Country:
India
Website Url:
http://www.cygenica.com
Total Employee:
1+
Status:
Active
Contact:
+91 7504 206 086
Email Addresses:
[email protected]
Total Funding:
1.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Font Awesome Apache Google Apps For Business PHP GoDaddy DNS PHP 7
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
Sharaf Yamani
Sharaf Yamani investment in Seed Round - CyGenica
SOSV
SOSV investment in Seed Round - CyGenica
Sami Mikati
Sami Mikati investment in Seed Round - CyGenica
VOYAGERS Health-Tech Fund
VOYAGERS Health-Tech Fund investment in Seed Round - CyGenica
David Rowan
David Rowan investment in Seed Round - CyGenica
Official Site Inspections
http://www.cygenica.com
- Host name: 26.128.153.160.host.secureserver.net
- IP address: 160.153.128.26
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "CyGenica"
CyGenica - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +91 7504 206 086 CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery …See details»
Cygenica
CYGENICA PRIVATE LIMITED 700 NIP, NCL Innovation Park, Dr. Homi Bhabha Road, Pashan, Pune – 411 008, Maharashtra, India. IRELAND CYGENICA PRIVATE LIMITED C/O O' Connor Pyne & Co. Limited Unit 4, Joyce House, …See details»
CyGenica - Funding, Financials, Valuation & Investors - Crunchbase
CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs and antibiotics. New. Resources. Advanced Search. ... How much funding has this …See details»
CYGENICA - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 12, 2025 CYGENICA - Developer of in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics. Raised a total funding of $1.4M over 2 rounds from 6 …See details»
CyGenica - Products, Competitors, Financials, Employees, …
About CyGenica. CyGenica is a biotechnology company focused on the development of drug and gene editing component delivery solutions. The company specializes in creating non-viral, non …See details»
CyGenica 2025 Company Profile: Valuation, Funding & Investors
CyGenica General Information Description. Developer of a molecular drug delivery device intended to assist in the programmable delivery of anticancer drugs, antibiotics and gene …See details»
Cygenica
Leading Through Innovation Delivering With Compassion Our team is our most important asset. We are driven by a strong commitment to make a difference and improve the quality of …See details»
Company: CyGenica - CRISPR Medicine
At CyGenica, we focus on enhanced quality of life and improved patient outcome by enabling safe, targeted, and affordable intracellular delivery of therapeutic molecules. Our platform is a non-toxic proprietary engineered biomolecule that …See details»
Odia Startup CyGenica is Transforming Cancer Care: The Story of …
Jul 7, 2021 Nusrat’s startup CyGenica has raised USD $1.4 million in a seed fund investment round, from an Irish fund led by global venture capital investor SOSV. ... ‘Mo College Abhijan’, …See details»
CyGenica Company Profile Funding & Investors
CyGenica is an Indo-Irish biotech startup developing world’s first molecular nanomachine for in-vitro and in-vivo delivery solutions for drugs and genetic therapies.See details»
CyGenica - Company Profile & Staff Directory - ContactOut
What We Do CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics. The most crucial issue of …See details»
A GEENIE in a Bottle: CyGenica’s Unique Non-Viral ... - CRISPR …
Oct 12, 2022 CyGenica is an Irish-Indian company founded in 2017 that specialises in novel cargo delivery technology. The company has developed a non-viral, non-toxic platform called …See details»
CyGenica – Startups at Venture Center
Oct 8, 2018 Cygenica is an early-stage, biotech company working on a unique drug delivery system. Their invention is a molecular nanomachine – CyCa-dds – that can deliver molecular …See details»
CyGenica Limited Secures USFDA Approval for Orphan Drug
Sep 12, 2023 /CNW/ -- CyGenica Limited, a dynamic biotech startup announced today a significant achievement in the battle against Glioblastoma Multiforme (GBM), a highly...See details»
Indian startup - CYGENICA is leading in building World’s ... - Medium
Dec 1, 2022 “CyGenica’s main goal is to develop the world’s safest molecular carrier. That is it in one line.”, says Dr Nusrat J M Sanghamitra, Founder and CEO at CyGenica.See details»
CyGenica Receives Orphan Drug Designation for Glioblastoma
Sep 12, 2023 CyGenica Limited, a dynamic biotech startup, has achieved a significant milestone in the fight against Glioblastoma Multiforme (GBM), an aggressive form of brain cancer. Dr. …See details»
Cygenica
CyGenica Presented in Intracellular Drug Delivery Summit 2023 , March 8-9, 2023, Boston “ Achieve Therapeutic Localization with Selective , Effective and Validated Delivery to …See details»
CyGenica Ltd. - SOSV
Jun 9, 2021 Get In Touch with CyGenica Ltd. Please tell us a little bit about yourself and why you'd like to get connected. CyGenica Ltd. + SOSV will follow up with you via email. Name …See details»
CyGenica Limited Secures USFDA Approval for Orphan Drug …
Sep 12, 2023 CyGenica Limited is a pioneering biotech startup based in Ireland and India, dedicated to advancing innovative intracellular delivery technologies and developing novel …See details»